0 Glyconutrients

Pages Introduction Dictionary Economic Alternatives Fucose Galactose Glucosamine Glucose Mannose N-Acetylneuraminic Acid Nacetylgalactosamine Sugar

CSHL Press publishes monographs, technical manuals, handbooks, review volumes, conference proceedings, scholarly journals and videotapes. These examine important topics in molecular biology, genetics, development, virology, neurobiology, immunology and cancer biology. Manuscripts for books and for journal publication are invited from scientists world wide.

Polysaccharopeptide (PSP), from Coriolus versicolor, has been used widely as an adjuvant to chemotherapy with demonstrated anti-tumor and broad immunomodulating effects. While PSP's mechanism of action still remains unknown, its enhanced immunomodulatory potential with acacia gum is of great interes …

Therapeutic monoclonal antibodies (TMA) provide an important means for treating diseases that were previously considered untreatable. Currently more than 40 full-size TMAs created primarily based on immunoglobulin G1 are widely used for treating various illnesses. Glycosylation of TMA is among other …

There may be good reason to take glucosamine supplements for symptoms other than joint problems.

Non-invasive GlycoCheck testing technology quantifies vessel density, red blood cell concentration, blood flow and glycocalyx function.

Hans Vink, PhD, PhD is one of the pioneers of glycocalyx research. He has been studying glycocalyx science and function since the 1980s.

Learn about how GlycoNet is funding glycomics research to help bridge the gap between fundamental advances and therapeutic applications in cancer, inflammation and cardiovascular disease The Canadian Glycomics Network (GlycoNet) aims to use the study of carbohydrates to improve human health. Find more information at www.glyconet.ca.

Glycomics is the study of carbohydrates or sugars in biological systems. Learn how glycomics research at GlycoNet is helping to better understand rare genetic diseases which impacts more than 600 million people worldwide. Glycomics presents an opportunity to develop novel treatments for rare genetic diseases that arise from deficiencies in sugar metabolism, such as Gaucher’s disease and Fabry’s disease. Understanding the biochemical and molecular basis of single gene disorders has led to therapeutic strategies for rare diseases and a realization that the development of many common disorders involves altered glycosylation pathways. Developing therapies for rare diseases thus potentially impacts common disorders. The Canadian Glycomics Network (GlycoNet) aims to use the study of carbohydrates to improve human health. Find more information at www.glyconet.ca.

Altered glycosylation is a universal feature of cancer cells, and certain glycan structures are well-known markers for tumor progression. This chapter discusses some glycan biosynthetic pathways that are frequently altered in cancer cells, the correlation between altered glycosylation and clinical prognosis, the genetic basis of some of these changes, and in vitro and in vivo studies that indicate the pathological importance of these pathways.

Intestinal permeability in preterm infants represents a critical balance between absorption of nutritional agents and protection from dangerous pathogens. This study identified the relationship between feeding type (human milk and formula) and intestinal ...

Glycoprotein quality control is categorized into three kinds of reactions; the folding of nascent glycoproteins, ER-associated degradation of misfolded or unassembled glycoproteins, and transport and sorting of correctly folded glycoproteins. In all three processes, N-glycans on the glycoproteins ar …

Glycoprotein quality control is categorized into three kinds of reactions; the folding of nascent glycoproteins, ER-associated degradation of misfolded or unassembled glycoproteins, and transport and sorting of correctly folded glycoproteins. In all three ...